Emmanouil Skalidis

Dr. Emmanouil Skalidis

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in European Heart Journal
Verified
Journal Article
Closed access
EBEmanuele Barbato
Emanuele Barbato
MNMarko Noc
Marko Noc
ABAndreas Baumbach
Andreas Baumbach
DDDariusz Dudek
Dariusz Dudek
MBMatjaz Bunc
Matjaz Bunc
MHMichael Haude
Michael Haude
Aims: The European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas of Interventional Cardiology has been developed to map interventional practice across European Society of Cardiology (ESC) member countries. Here we present the main findings of a 16-country survey in which we examine the national availability of interventional infrastructure, human resource, and procedure volumes. Methods and results: Sixteen ESC member countries participated in the EAPCI Atlas survey. Interventional data were collected by the National Cardiac Society of each participating country. An annual median of 5131 [interquartile range (IQR) 4013–5801] diagnostic heart procedures per million people were reported, ranging from 7000 in Turkey and Germany. Procedure rates showed significant correlation (r = 0.67, P = 0.013) with gross national income (GNI) per capita. An annual median of 2478 (IQR 1690–2633) percutaneous coronary interventions (PCIs) per million people were reported, ranging from 3000 in Switzerland, Poland, and Germany. Procedure rates showed significant correlation with GNI per capita (r = 0.62, P = 0.014). An annual median of 48.2 (IQR 29.1–105.2) transcatheter aortic valve implantation procedures per million people were performed, varying from 100 per million people in Denmark, France, Switzerland, and Germany. Procedure rates showed significant correlation with national GNI per capita (r = 0.92, P < 0.001). Conclusion: The first report from the EAPCI Atlas has shown considerable international heterogeneity in interventional cardiology procedure volumes. The heterogeneity showed association with national economic resource, a reflection no doubt of the technological costs of developing an interventional cardiology service.

1 March 2011 in Atherosclerosis
Verified
Journal Article
Closed access
ESEmmanouil Skalidis
Emmanouil Skalidis
MHMichalis I. Hamilos
Michalis I. Hamilos
GCGregory Chlouverakis
Gregory Chlouverakis
EZEvangelos A. Zacharis
Evangelos A. Zacharis
PVPanos E. Vardas
Panos E. Vardas

Verified
Journal Article
Open access
PDF file
SPSTYLIANOS PETOUSIS
STYLIANOS PETOUSIS
ESEmmanouil Skalidis
Emmanouil Skalidis
EZEvangelos Zacharis
Evangelos Zacharis
GKGeorge Kochiadakis
George Kochiadakis
MHMichalis Hamilos
Michalis Hamilos
Interventional cardiologists in everyday practice are often confronted with calcified coronary lesions indicated for percutaneous transluminal coronary angioplasty (PTCA). PTCA of calcified lesions is associated with diverse technical challenges resulting in suboptimal coronary stenting and adverse long-term clinical outcomes. Angiography itself offers limited information regarding coronary calcification, and the adjuvant use of intracoronary imaging such as intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT) can guide the treatment of calcified coronary lesions, optimizing the different stages of the procedure. This review offers a description of why, when, and how to use intracoronary imaging for PTCA of calcified coronary lesions in order to obtain the most favorable results. We used the PubMed and Google Scholar databases to search for relevant articles. Keywords were calcified coronary lesions, intracoronary imaging, IVUS, OCT, coronary calcium modification techniques, PTCA, and artificial intelligence in intracoronary imaging. A total of 192 articles were identified. Ninety-one were excluded because of repetitive or non-important information.

27 October 2022 in European Heart Journal
Verified
Journal Article
Open access
PDF file
ISIoannis Skalidis
Ioannis Skalidis
SFStephane Fournier
Stephane Fournier
ESEmmanouil Skalidis
Emmanouil Skalidis
NMNiccolo Maurizi
Niccolo Maurizi
Digital health and telemedicine flourished during the recent pandemic and modified the traditional physical way of patient–doctor interaction by using digital means and internet. While technology has become integral to cardiovascular medicine and augmented and virtual reality (AR/VR) are bringing modern possibilities, healthcare is arriving closer than ever to the merge of virtual and real worlds. The Metaverse, which is currently trending among various industries, represents the convergence of both worlds into an immersive online virtual interconnected environment where its participants will actively engage with 3D content and interact via digital avatars. Although the introduction of the Metaverse has provoked extensive debate regarding its theoretical applicability in healthcare,1 there are no reports exploring the scientific evidences produced to date and which projects are currently ongoing in the field of healthcare and cardiology.

1 November 2017 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
George LatsiosGeorge Latsios
George Latsios
GMGeorge Mpompotis
George Mpompotis
KTKostas Tsioufis
Kostas Tsioufis
KTKostas Toutouzas
Kostas Toutouzas
ESEmmanouil Skalidis
Emmanouil Skalidis
DTDimitris Tousoulis
Dimitris Tousoulis
The incidence of Cardiac (Cardio-Pulmonary) Arrest (CA) in the Catheterization Laboratory is not common. However, not only does it happen occasionally but its frequency tends to increase due to the increase in the overall number and complexity of interventions performed by interventional cardiologists. Therefore, certified knowledge and application of the ALS (Advanced Life Support) protocols by trained Catheterization Laboratory staff is imperative in many countries, by local Hospital standards and also by Law. The frequency/epidemiology of CA in the Cath Lab is difficult to be accurately estimated. The etiology (usually ventricular fibrillation but also other rhythms) refers to both the underlying coronary angiography event/indication) (eg STEMI) but also to the complications of the operation itself (ie coronary angiography/intervention). The standardized approaches that need to be followed to increase the survival rate of these patients include - within the general ALS guidelines- cardio pulmonary resuscitation (CPR) in the Cath Lab. During CPR, chest compressions are not easy to apply, they are often discontinued while exposing the staff to a high dose of ionizing radiation. The use of automated devices is supported by the guidelines and has a theoretical advantage by offering high quality chest compressions while simultaneously allowing the invasive cardiologist to focus on the treatment of the underlying cause. Patients rescued from out-of-hospital CA with return of spontaneous circulation (ROSC), regardless the cause of the CA, should be transported to a hospital with a Cath Lab for further investigation and in cases of an acute coronary syndrome (ACS) primary coronary intervention, if needed. In some Cath Labs/Cities worldwide, an effort is being made to transfer patients in CA that do not respond to multiple defibrillations, under CPR to a Cath Lab to provide advanced circulatory support and coronary reperfusion.

28 December 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CBChrysoula Boutari
Chrysoula Boutari
CRChristos Rizos
Christos Rizos
MDMichael Doumas
Michael Doumas
GLGeorge Liamis
George Liamis
ISIoannis Skoumas
Ioannis Skoumas
Evangelos LiberopoulosEvangelos Liberopoulos
Evangelos Liberopoulos
Familial hypercholesterolemia (FH) and type 2 diabetes mellitus (T2DM) are both associated with a high risk of atherosclerotic cardiovascular disease (ASCVD). Little is known about the prevalence of T2DM and its association with ASCVD risk in FH patients. This was a cross-sectional analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH) including adults with FH (n = 1719, mean age 51.3 ± 14.6 years). Of FH patients, 7.2% had a diagnosis of T2DM. The prevalence of ASCVD, coronary artery disease (CAD), and stroke was higher among subjects with T2DM compared with those without (55.3% vs. 23.3%, 48.8% vs. 20.7%, 8.3% vs. 2.7%, respectively, p < 0.001). When adjusted for age, systolic blood pressure, smoking, body mass index, hypertension, waist circumference, triglyceride levels, high-density lipoprotein cholesterol levels, and gender, T2DM was significantly associated with prevalent ASCVD [OR 2.0 (95% CI 1.2–3.3), p = 0.004]. FH patients with T2DM were more likely to have undergone coronary revascularization than those without (14.2% vs. 4.5% for coronary artery bypass graft, and 23.9% vs. 11.5% for percutaneous coronary intervention, p < 0.001). T2DM is associated with an increased risk for prevalent ASCVD in subjects with FH. This may have implications for risk stratification and treatment intensity in these patients.